CD274 and neoplasm: One mechanism for immune evasion is the expression of immune checkpoint molecules, such as PD-L1 by tumour cells, and targeting these checkpoint molecules with antibodies is emerging as an effective therapeutic strategy against lung cancer3,48,49.